| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |